🇨🇭 Switzerland Country × Condition
coronary artery disease Clinical Trials in Switzerland
Active clinical trials for coronary artery disease with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇨🇭 Switzerland
Active Trials in Switzerland (4)
NCT07397845
Recruiting
Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
Enrollment
1,380 pts
Country
🇨🇭 Switzerland
Translumina GmbH
View Trial → NCT04185285
Recruiting
Percutaneous Coronary Intervention Registry FRIBOURG
Enrollment
3,000 pts
Country
🇨🇭 Switzerland
University of Freiburg
View Trial → NCT01838148
Recruiting
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Enrollment
4,000 pts
Country
🇨🇭 Switzerland
University Hospital, Basel, Switzer...
View Trial → NCT06075602
Recruiting
COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
Enrollment
5,000 pts
Country
🇨🇭 Switzerland
Luzerner Kantonsspital
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in Switzerland?
There are currently 4 active clinical trials for coronary artery disease with sites in Switzerland, of which 4 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Switzerland?
To join a coronary artery disease clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Switzerland?
Active coronary artery disease trials in Switzerland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology